Pharmacokinetic aspects of drug metabolism.
D000284:Administration, Oral; D000818:Animals; D000970:Antineoplastic Agents / Q000097:blood; D001391:Azo Compounds / Q000097:blood; D003622:Dapsone / Q000097:blood / Q000652:urine; D004285:Dogs; D004358:Drug Therapy; D006207:Half-Life; D006801:Humans; D007093:Imidazoles / Q000097:blood; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007700:Kinetics; D008099:Liver / Q000378:metabolism; D008433:Mathematics; D008954:Models, Biological; D004364:Pharmaceutical Preparations / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000652:urine; D010600:Pharmacology; D010672:Phenytoin / Q000378:metabolism; D011433:Propranolol / Q000097:blood; D012459:Salicylates / Q000378:metabolism; D013997:Time Factors
D000970:Antineoplastic Agents; D001391:Azo Compounds; D007093:Imidazoles; D004364:Pharmaceutical Preparations; D012459:Salicylates; D010672:Phenytoin; D003622:Dapsone; D011433:Propranolol